Results

Total Results: over 10,000 records

Showing results for "months".

161. Final Research Plan: Vision in Children Ages 6 Months to 5 Years: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/vision-screening-children-ages-6-months-5-years
     July 24, 2025 - Print in progress Final Research Plan Vision in Children Ages 6 Months … Does screening for amblyopia, its risk factors, and refractive error in children ages 6 months to 5 years … Does treatment of amblyopia, its risk factors, and refractive error in children ages 6 months to 5 years … Does treatment of amblyopia, its risk factors, and refractive error in children ages 6 months to 5 years … Include Exclude Populations All KQs: Children ages 6 months to 5 years KQs 1–3: Children

162. 2018 National Healthcare Quality and Disparities Report: Appendix A (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2018qdr-appa2.pdf
     January 01, 2018 - Data Source Number of Years Adults who had a doctor’s office or clinic visit in the last 12 months … -4.15 0.0 MEPS 15 (2002- 2016) Adults who had a doctor’s office or clinic visit in the last 12 months … 3.5 0.0 0.00 MEPS 15 (2002- 2016) Adults who had a doctor’s office or clinic visit in the last 12 months … MEPS 15 (2002- 2016) Adults who reported that home health providers talk about pain in the last 2 months … -3.21 0.0 0.00 HCAHPS 9 (2009- 2017) Adults who had a doctor’s office or clinic in the last 12 months

163. Cannabis-2023-Surv-Rep-4-Table-E-5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-table-E-5.xlsx
     January 01, 2023 - NR + 1.75 mg/d 3 months: 3.15 mg/d vs. 2,372 mg/d vs. … NR + 2.85 mg/d 6 months: 3.05 mg/d + 2,295.5 mg/d vs. … NR + 3.02 mg/d 26 (6 months) Short and intermediate A vs. B vs. … NA CBD: 202.18 (SD 345.23) 12 weeks (3 months) Short A vs. … NA 84 (21 months) Long NR None NR NR NR NR NR A vs.

164. Cannabis-2022-Surv-Rep-4-Table-F5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-table-F5.xlsx
     January 01, 2022 - NR + 1.75 mg/d 3 months: 3.15 mg/d vs. 2,372 mg/d vs. … NR + 2.85 mg/d 6 months: 3.05 mg/d + 2,295.5 mg/d vs. … NR + 3.02 mg/d 26 (6 months) Short and intermediate A vs. B vs. … NA CBD: 202.18 (SD 345.23) 12 weeks (3 months) Short A vs. … NA 84 (21 months) Long NR None NR NR NR NR NR A vs.

165. Cer-250-Cannabis-2025-Surv-Rep-Update-Table-E5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-table-e5.xlsx
     January 01, 2025 - NR + 1.75 mg/d 3 months: 3.15 mg/d vs. 2,372 mg/d vs. … NR + 2.85 mg/d 6 months: 3.05 mg/d + 2,295.5 mg/d vs. … NR + 3.02 mg/d 26 (6 months) Short and intermediate A vs. B vs. … NA CBD: 202.18 (SD 345.23) 12 weeks (3 months) Short A vs. … NA 84 (21 months) Long NR None NR NR NR NR NR A vs.

166. Adolescent Depression Remission/Response Measure Description (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/depression/chipra-247-section-2.pdf
     June 02, 2025 - initial PHQ-9 or PHQ-A score greater than 9 who achieved remission or response within four to eight months … -9 or PHQ-A score less than 5 Numerator 2: Patients who achieved response within four to eight months … Remission Remission is defined as a PHQ-9 or PHQ-A score less than 5 within 4 to 8 months of the index … Numerator 1 (Remission) Patients who achieved remission within four to eight months from the initial … Numerator 2 (Response) Patients who achieved response within four to eight months from the initial

167. CAHPS Cancer Care Supplemental Items (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/suppl-items-cancer-english-557a.pdf
     June 02, 2025 - In the last 6 months, did you contact this cancer center with a medical question after regular office … In the last 6 months, when you contacted this cancer center after regular office hours, how often did … In the last 6 months, did your [CANCER TREATMENT MODALITY] team tell you what the next steps in your … In the last 6 months, how often did your [CANCER TREATMENT MODALITY] team explain those results in a … In the last 6 months, did your [CANCER TREATMENT MODALITY] team prescribe medicine that you had not

168. SOPS Medical Office Survey (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/medical-office-survey-english-2023.docx
     January 01, 2023 - Daily Weekly Monthly Several times in the past 12 months Once or twice in the past 12 months … Daily Weekly Monthly Several times in the past 12 months Once or twice in the past 12 months … Not in the past 12 months Does Not Apply or Don’t Know Medication 6. … Problems once or twice in the past 12 months No problems in the past 12 months Does … Less than 2 months d. 3 years to less than 6 years b. 2 months to less than 1 year e. 6 years

169. Executive Summary_Comparative Effectiveness Review No. 261_Postpartum Care up to 1 Year After Pregnancy: A Systematic Review and Meta-Analysis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-261-postpartum-care-executive-summary.pdf
     June 01, 2023 - postpartum), anxiety symptoms (up to 2 months), hospital readmission (up to 3 months), or other unplanned … but not at 1 month or 3 months. … and 6 months and of exclusive breastfeeding at 3 months (all moderate SoE) … by 3 months or other unplanned care utilization up to 2 months). … but not at 1 month or 3 months.

170. 2014 CAHPS Clinician & Group Survey Database Chartbook (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/cahps/cahps-database/2014_cg_cahps_chartbook.pdf
     January 01, 2014 - Q19 In the last 12/6 months, how often did this provider show respect for what you had to say? … Q20 In the last 12/6 months, how often did this provider spend enough time with you? … Q25 In the last 12/6 months, how often did this provider spend enough time with you? … Q27 In the last 12/6 months, how often did this provider spend enough time with your child? … Q32 In the last 12/6 months, how often did this provider spend enough time with your child?

171. Ncinqtobaccousehelpspec-Prov (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/NCINQTobaccoUseHelpSpec-Prov.pdf
     June 02, 2025 - Measurement Year 12 months. … may not have more than a 1- month gap in coverage (i.e., an adolescent whose coverage lapses for 2 months … December 31 of the measurement year. 18 months. Benefit Event/Diagnosis Medical. … Documentation of a face-to-face visit to the primary care practice during the 12 months prior to the … adolescent is a tobacco user AND had any of the following during the measurement year or the six months

172. Introducing Electronic Screening Tools for Developmental Delay and Autism into Pediatric Primary Care: Effects on Screening Documentation (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/Natzke-presentation.pdf
     December 01, 2015 - 47–107 days (1.5–3.5 months) Postpartum depression Edinburgh 9 months 261–364 days (8.5–12 months … ) Developmental delay Ages & Stages Questionnaire, 3rd Edition2 18 months 505–640 days (16.5–21 … months) Developmental delay and autism Ages & Stages Questionnaire, 3rd Edition2 and M-CHAT … 24 months 641–819 days (21–27 months) Developmental delay and autism Ages & Stages Questionnaire … , 3rd Edition2 and M-CHAT 30 months 820–1,003 days (27–33 months) Developmental delay Ages & Stages

173. Evidence Summary_Comparative Effectiveness Review No. 247_Interventional Treatments for Acute and Chronic Pain: Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-247-interventional-treatments-acute-chronic-pain-evidence-summary_0.pdf
     September 01, 2021 - Outcomes were analyzed at 1 to 2 weeks, 2 to 4 weeks, 1 to 6 months, 6 to 12 months, and 12 months and … (10 trials, N=1094), 6 to 12 months (8 trials, N=993), and 12 months and longer (9 trials, N=965), … (7 trials, N=637), 6 to 12 months (6 trials, N=690), and ≥12 months (6 trials, N=612). … 2 to 4 weeks and 6 to 12 months) … at 6 weeks and 3 months; insufficient for 6, 12, and 24 months).

174. Undiagnosed cancer cases in the US during the first 10 months of the COVID-19 pandemic. | PSNet
     psnet.ahrq.gov/issue/undiagnosed-cancer-cases-us-during-first-10-months-covid-19-pandemic
     September 01, 2016 - Study Undiagnosed cancer cases in the US during the first 10 months of the COVID- … Undiagnosed cancer cases in the US during the first 10 months of the COVID-19 pandemic. … Diagnoses of included cancers were 6% lower than would be expected, even 10 months after the start of … Undiagnosed cancer cases in the US during the first 10 months of the COVID-19 pandemic.

175. Section 12, Tables 4 and 5. (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-141-section-12-table-4-5.pdf
     December 31, 2010 - ± 497 (73%) 182 (27%) 651,207 (79%) 177,805 (21%) Coverage for majority of eligibility months … Fee-for-service ± Managed care ± 318 (47%) 361 (53%) 169,708 (20%) 659,304 (80%) Months … of medical assistance eligibility 2009-2011 < 12 months ± 13-24 months ± 25-35 months ± 36 months … 2009 to 2011 for children under age 19 on 7/1/10 with a minimum eligibility of 1 month in 2010 and 2 months

176. Pediatric Units | Agency for Healthcare Research and Quality
     www.ahrq.gov/hai/cusp/clabsi-final-companion/clabsicomp4b.html
     January 01, 2013 -   Pre-Intervention Post-Intervention Baseline Q1 Q2 Q3 Q4 Q5 Q6 12 Months … Months 1-3 Months 4-6 Months 7-9 Months 10-12 Months 13-15 Months

177. NICU Family Information Packet, Appendix B, Sleep in Preterm Infants (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/nicu_toolkit/nicupacket-apb-sleep.pdf
     June 02, 2025 - SIDS ■ Preterm infants are known to be at higher risk for SIDS; high-risk period lasts up to 10 months … ■ Newborn infant spends 2/3 of each day asleep; by 6 months only half of each day is spent asleep … Studies have shown that these benefits are most pronounced after discharge and persist for several months … longer periods uninterruptedly are more likely to obtain high scores on the Bayley mental scale at 6 months

178. CAHPS Cancer Care Supplemental Items (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/suppl-items-cancer-info-english-557-6a.docx
     June 02, 2025 - In the last 6 months, did your [CANCER TREATMENT MODALITY] team tell you what the next steps in your … In the last 6 months, how often did your [CANCER TREATMENT MODALITY] team explain those results in a … In the last 6 months, did your [CANCER TREATMENT MODALITY] team prescribe medicine that you had not taken … In the last 6 months, did your [CANCER TREATMENT MODALITY] team explain what that medicine was for in

179. Cer-250-Cannabis-2024-Surv-Rep-Update-Table-E5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-table-e5.xlsx
     January 01, 2024 - NR + 1.75 mg/d 3 months: 3.15 mg/d vs. 2,372 mg/d vs. … NR + 2.85 mg/d 6 months: 3.05 mg/d + 2,295.5 mg/d vs. … NR + 3.02 mg/d 26 (6 months) Short and intermediate A vs. B vs. … NA CBD: 202.18 (SD 345.23) 12 weeks (3 months) Short A vs. … NA 84 (21 months) Long NR None NR NR NR NR NR A vs.

180. Cer-251-Integrated-Pain-Management-App-F (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-251-integrated-pain-management-app-F.xlsx
     January 01, 2020 - : Yes 24 months: Overall No, Differential Yes Yes Yes Fair Table G-1. … : Yes 18 months: Overall Yes; Differential No Yes Yes Fair Johansson, 1998 Unclear Unclear Unclear … : Yes 24 months: Overall No, Differential Yes Yes Yes Fair Kool 2005/2007 Yes Yes Yes Yes No No Yes … : Yes 12 months: Overall, No; Differential, Yes Yes Yes Fair Tavafian 2011, 2014, 2017a, 2017b Yes … Yes Yes Yes No No Yes 3, 6, 12, 24 months: Yes; 30 months: Overall No, Differential Yes No Yes Fair